West Pharmaceutical stock price target raised to $390 from $350 at Evercore ISI
PositiveFinancial Markets

West Pharmaceutical's stock price target has been raised from $350 to $390 by Evercore ISI, reflecting growing confidence in the company's performance and potential for future growth. This adjustment is significant as it indicates analysts' optimism about West Pharmaceutical's market position and profitability, which could attract more investors and positively impact the stock's performance.
— Curated by the World Pulse Now AI Editorial System






